IVI RMA North America to Showcase Leading Infertility Research at ASRM 2024
Over 50 Research Studies by IVI RMA North America Set to Advance Infertility Care at ASRM 2024 IVI RMA North America, which encompasses Reproductive Medicine Associates and Boston IVF, will…
Tasso, Inc. Survey: One in Three Patients Delay Blood Tests Due to Anxiety and Pain
Survey Reveals 78% of Patients Experience Anxiety During Blood Draws; 74% Want Painless Home Collection Solutions Tasso, Inc., a leading provider of patient-centric blood collection solutions, surveyed over 600 adults…
Charles River Introduces New Retrogenix® Non-Human Protein Library
Charles River Laboratories International, Inc. (NYSE: CRL) has launched the Retrogenix® Non-Human Protein Library, a first-in-class in vitro tool designed to help biopharmaceutical clients assess off-target binding within a non-human…
1910 Genetics Launches CANDID-CNS™, an AI Model Surpassing Blood-Brain Barrier Permeability Standards
1910 Genetics Launches CANDID-CNS™, an AI Model for Blood-Brain Barrier Permeability Prediction 1910 Genetics, a biotechnology company specializing in small and large molecule drug discovery, has announced the launch of…
Eric Murphy, Ph.D., CEO of Alterome, Named Goldman Sachs’ Top 100 Entrepreneur for 2024
Alterome Therapeutics, Inc. Recognized at Goldman Sachs Builders and Innovators Summit Alterome Therapeutics, Inc., a biopharmaceutical company specializing in next-generation small molecule targeted therapies for cancer, announced that Eric Murphy,…
iProov Sees 60% Growth in Transactions Amid Rising Demand for Biometric Solutions
iProov Reports 63% Transaction Growth Amid Rising Demand for Biometric Solutions iProov, a leader in biometric identity solutions, announced a remarkable 63% increase in transaction volume on its platform from…
Minze Health Secures $5.3 Million to Advance Prescription Digital Therapeutics and U.S. Market Commercialization
Minze Health Secures $5.3 Million in Funding to Advance Digital Health Solutions for Urology Minze Health, a leader in digital health solutions tailored for urology, has successfully raised $5.3 million…
Modivcare and Tenovi Partner to Improve Respiratory Care with Hailie® Smart Inhalers
Modivcare Partners with Tenovi to Enhance Respiratory Care Using Adherium’s Hailie® Smart Inhalers Modivcare Inc., a prominent technology-enabled healthcare services company, has announced a partnership with Tenovi, a pioneer in…
Sage Therapeutics Restructures to Prioritize ZURZUVAE® Launch and Streamline Development Pipeline
Sage Therapeutics, Inc. (Nasdaq: SAGE) has unveiled a strategic reorganization initiative aimed at prioritizing the commercialization of ZURZUVAE® for postpartum depression while sharpening its focus on pipeline development, including the…
Marinus Pharma Shares Phase 3 RAISE Trial Results on Refractory Status Epilepticus at Neurocritical Care 2024
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a company focused on developing innovative therapies for seizure disorders, has shared new data from its Phase 3 RAISE trial on intravenous (IV) ganaxolone for…
AMIVAS Unveils Europe’s First Licensed Treatment for Severe Malaria
Artesunate AMIVAS, the first fully licensed treatment for severe malaria in Europe, is now available for purchase across Europe and the U.K. through Nordic Prime in Denmark. Approved by the…
Helfie AI Adds Healthcare Experts Antonin de Fougerolles and Cheryl Buxton to Board of Directors
Helfie AI, a global leader in mobile health technology, has strengthened its Board of Directors with the addition of two healthcare veterans. Antonin (Tony) de Fougerolles, PhD, a distinguished scientist…